Navigation Links
HemoSonics Appoints Timothy Fischer President and Chief Executive Officer
Date:8/5/2014

CHARLOTTESVILLE, Va., Aug. 5, 2014 /PRNewswire/ -- HemoSonics, a medical diagnostic company developing a novel point-of-care instrument to measure coagulation, announced today that it has named Timothy J. Fischer as President and Chief Executive Officer. Fischer has been a pioneer in the in vitro diagnostics industry in the fields of hematology, oncology and pathology for the past 25 years. He has led the design, development and commercialization of dozens of novel diagnostic products. He holds over 40 patents and has authored numerous publications.

"We are pleased and fortunate to have Tim leading our Company as we turn the corner to commercialization," said William Moffitt, Chairman of the Board of Managers for HemoSonics. "His extensive knowledge of hemostasis and his experience in building high performing product development teams will enable us to fulfill our vision of delivering critical patient information at the point of care."

Prior to joining HemoSonics, Fischer served as Chief Operating Officer for LipoScience, a publicly traded in vitro diagnostics company. At LipoScience, he led the successful development of the Vantera® Clinical Analyzer from concept through development, regulatory approval and market adoption. Before joining LipoScience, he served as Vice President of Development for the Women's Health and Cancer business unit at Becton Dickinson (BD) and as the Vice President of Product Development for TriPath Oncology.

"HemoSonics' novel technology enables an unparalleled product that will save lives and reduce healthcare costs by providing comprehensive information in an easy to use format," said Fischer. "I am thrilled to be part of a team that will revolutionize hemostasis testing and directly impact patient care in the critical care setting."

Fischer holds a Bachelor of Science degree in Biology from Indiana University.

About HemoSonics, LLC

HemoSonics, LLC (http://hemosonics.com), an in vitro diagnostics company, is developing and commercializing a novel ultrasound technology to address a significant unmet need in critical patient care.  Bleeding and clotting disorders are a major cause of morbidity and mortality, leading to complications, worse outcomes and longer hospital stays. HemoSonics is developing a platform and assays to identify coagulation dysfunctions in whole blood at the point-of-care in acute care settings, enabling physicians to improve quality of care while reducing overall healthcare costs.

HemoSonics' technology and products are currently labeled as Research Use Only and are not intended for clinical use at this time.

HemoSonics Contact:
Megan Shaw
(434) 260-0682
mshaw@hemosonics.com


'/>"/>
SOURCE HemoSonics, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
2. invendo medical Appoints Nachum (Homi) Shamir To The Companys Board Of Directors
3. Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
4. Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
5. ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development
6. Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
7. Pharmavite Appoints Timothy Toll Chief Customer Officer
8. Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer
9. BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
10. PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board
11. Nonin Medical Appoints Ash Keswani Vice President of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)...  John Seng, founder of Spectrum Science Communications , announced ... Executive Officer following two consecutive years of high double digit growth ... in 2014 and assumed management of the firm that Seng founded ... as Healthcare Agency of the Year and was selected among the ... ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Growth and Demand Forecast to 2022" report to their offering. ... , , ... test market is expected to grow at a CAGR of 4.5% ... is witnessing high growth, due to growing female geriatric population and ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare ... , ... policymakers, and stakeholders crucial insight into Switzerland ; a ... to some of the world,s most important international health institutions as well ... with a number one ranking globally in terms of ease of doing ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... Dr. Barry M. ... Cosmetic Plastic Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium ... the newest techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is ...
(Date:12/5/2016)... and MALVERN, PA (PRWEB) , ... ... ... Supplies Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced ... – Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern ...
(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina ... of New York was founded by James M. Maisel, MD and has been providing tertiary ... has always followed a legacy of surpassing expectations amongst her peers. Growing up in ...
(Date:12/5/2016)... Houston, Texas (PRWEB) , ... ... ... surgeon, Dr. Henry Mentz won "Best Surgical Facial Rejuvenation" at the 2016 ... held in Paris, France. , The Aesthetic & Anti-aging Medicine European ...
Breaking Medicine News(10 mins):